+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Veterinary CRO Market by Service Type, Application, End User: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 4990120
  • Report
  • December 2019
  • Region: Global
  • 181 pages
  • Allied Analytics LLP
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Clinvet
  • KLIFOVET AG
  • Oncovet Clinical Research
  • ONDAX Scientific
  • Triveritas
  • VetPharm Inc.
  • MORE
The global veterinary CRO market was valued at $485.5 million in 2018, and is expected to reach $894.7 million by 2026, registering a CAGR of 7.9% from 2019 to 2026. Contract research organizations (CROs) are companies that aid in conducting research for a sponsor company. Moreover, veterinary CROs are companies, which are specialized in-vivo studies that involve companion animals. Sponsor companies seek provision from veterinary CROs to support research and development programs for biopharmaceutical industries. Furthermore, different types of services are provided by veterinary CROs such as clinical trials, toxicology, and market authorization & regulatory support. These services are utilized by veterinary medicine manufacturers to test the safety and efficacy of veterinary drugs, which are used in different indications such as oncology, neurology, and infectious diseases.

The factors that boost the growth of the veterinary CRO market include a surge in ownership of companion animals and rise in animal health expenditure. Furthermore, other factors such as increase in prevalence of various diseases among companion animal acts as a major factor that contributes toward the growth of the market. However, lack of standardization in veterinary CROs is a factor that restrains the growth of the market. Conversely, a surge in awareness related to animal healthcare across the globe is expected to provide lucrative opportunities in the market during the forecast period.

The veterinary CRO market is segmented into service type, animal type, indication, and region. On the basis of service type, the market is divided into clinical trials, toxicology, market authorization & regulatory support, and others. By animal type, the market is classified into dogs, cats, and others. Depending on indication, it is categorized into oncology, infectious disease, neurology, and others. Region wise, it is analyzed across North America (U.S, Canada, and Mexico) and Europe (Germany, France, Italy, Spain, UK and Rest of Europe), Asia-Pacific (Japan, China, Australia, rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • This report entails a detailed quantitative analysis along with the current global veterinary CRO market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • A qualitative analysis based on innovative service types facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments

By Service Type
  • Clinical Trials
  • Toxicology
  • Market Authorization & Regulatory Support
  • Others
By Animal Type
  • Dogs
  • Cats
  • Others
By Indication
  • Oncology
  • Infectious Disease
  • Neurology
  • Others
By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest Of LAMEA
List of key players profiled in the report:
  • Charles River Laboratories, Inc.
  • Clinvet
  • KLIFOVET AG
  • Löhlein & Wolf Vet Research
  • Oncovet Clinical Research
  • ONDAX Scientific
  • Triveritas
  • Veterinary Research Management (VRM) Ltd
  • VetPharm, Inc.
  • VETSPIN SRL
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • AlcheraBio
  • Likarda
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Clinvet
  • KLIFOVET AG
  • Oncovet Clinical Research
  • ONDAX Scientific
  • Triveritas
  • VetPharm Inc.
  • MORE
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.1.1. Top Impacting Factors
2.1.2. Top Investment Pockets
2.2. CXO Perspective

Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Porter'S Five Forces Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Thereat of New Entrants
3.2.4. Threat of Substitutes
3.2.5. Intensity of Competitive Rivalry
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Surge In Ownership of Companion Animals
3.3.1.2. Rise In Animal Health Expenditure
3.3.1.3. Increase In Prevalence of Various Diseases Among Companion Animals
3.3.2. Restraint
3.3.2.1. Lack of Standardization In Veterinary Cros
3.3.3. Opportunity
3.3.3.1. Surge In Awareness Related To Animal Healthcare
3.3.4. Impact Analysis

Chapter 4: Veterinary Cro Market, By Service Type
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Clinical Trials
4.2.1. Key Market Trends And Growth Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis By Country
4.3. Toxicology
4.3.1. Key Market Trends And Growth Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis By Country
4.4. Market Authorization And Regulatory Support
4.4.1. Key Market Trends And Growth Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis By Country
4.5. Others
4.5.1. Key Market Trends And Growth Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis By Country

Chapter 5: Veterinary Cro Market, By Animal Type
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Dogs
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis By Country
5.3. Cats
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis By Country
5.4. Others
5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis By Country

Chapter 6: Veterinary Cro Market, By Indication
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Oncology
6.2.1. Market Size And Forecast, By Region
6.2.2. Market Analysis By Country
6.3. Infectious Disease
6.3.1. Market Size And Forecast, By Region
6.3.2. Market Analysis By Country
6.4. Neurology
6.4.1. Market Size And Forecast, By Region
6.4.2. Market Analysis By Country
6.5. Others
6.5.1. Market Size And Forecast, By Region
6.5.2. Market Analysis By Country

Chapter 7: Veterinary Cro Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends And Opportunities
7.2.2. Market Analysis By Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Market Size And Forecast, By Service Type
7.2.2.1.2. U.S. Market Size And Forecast, By Animal Type
7.2.2.1.3. U.S. Market Size And Forecast, By Indication
7.2.2.2. Canada
7.2.2.2.1. Canada Market Size And Forecast, By Service Type
7.2.2.2.2. Canada Market Size And Forecast, By Animal Type
7.2.2.2.3. Canada Market Size And Forecast, By Indication
7.2.2.3. Mexico
7.2.2.3.1. Mexico Market Size And Forecast, By Service Type
7.2.2.3.2. Mexico Market Size And Forecast, By Animal Type
7.2.2.3.3. Mexico Market Size And Forecast, By Indication
7.2.3. North America Market Size And Forecast, By Service Type
7.2.4. North America Market Size And Forecast, By Animal Type
7.2.5. North America Market Size And Forecast, By Indication
7.3. Europe
7.3.1. Key Market Trends And Opportunities
7.3.2. Market Analysis By Country
7.3.2.1. Germany
7.3.2.1.1. Germany Market Size And Forecast, By Service Type
7.3.2.1.2. Germany Market Size And Forecast, By Animal Type
7.3.2.1.3. Germany Market Size And Forecast, By Indication
7.3.2.2. France
7.3.2.2.1. France Market Size And Forecast, By Service Type
7.3.2.2.2. France Market Size And Forecast, By Animal Type
7.3.2.2.3. France Market Size And Forecast, By Indication
7.3.2.3. UK
7.3.2.3.1. UK Market Size And Forecast, By Service Type
7.3.2.3.2. UK Market Size And Forecast, By Animal Type
7.3.2.3.3. UK Market Size And Forecast, By Indication
7.3.2.4. Italy
7.3.2.4.1. Italy Market Size And Forecast, By Service Type
7.3.2.4.2. Italy Market Size And Forecast, By Animal Type
7.3.2.4.3. Italy Market Size And Forecast, By Indication
7.3.2.5. Spain
7.3.2.5.1. Spain Market Size And Forecast, By Service Type
7.3.2.5.2. Spain Market Size And Forecast, By Animal Type
7.3.2.5.3. Spain Market Size And Forecast, By Indication
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe Market Size And Forecast, By Service Type
7.3.2.6.2. Rest of Europe Market Size And Forecast, By Animal Type
7.3.2.6.3. Rest of Europe Market Size And Forecast, By Indication
7.3.3. Europe Market Size And Forecast, By Service Type
7.3.4. Europe Market Size And Forecast, By Animal Type
7.3.5. Europe Market Size And Forecast, By Indication
7.4. Asia-Pacific
7.4.1. Key Market Trends And Opportunities
7.4.2. Market Analysis By Country
7.4.2.1. Japan
7.4.2.1.1. Japan Market Size And Forecast, By Service Type
7.4.2.1.2. Japan Market Size And Forecast, By Animal Type
7.4.2.1.3. Japan Market Size And Forecast, By Indication
7.4.2.2. China
7.4.2.2.1. China Market Size And Forecast, By Service Type
7.4.2.2.2. China Market Size And Forecast, By Animal Type
7.4.2.2.3. China Market Size And Forecast, By Indication
7.4.2.3. Australia
7.4.2.3.1. Australia Market Size And Forecast, By Service Type
7.4.2.3.2. Australia Market Size And Forecast, By Animal Type
7.4.2.3.3. Australia Market Size And Forecast, By Indication
7.4.2.4. Rest of Asia-Pacific
7.4.2.4.1. Rest of Asia-Pacific Market Size And Forecast, By Service Type
7.4.2.4.2. Rest of Asia-Pacific Market Size And Forecast, By Animal Type
7.4.2.4.3. Rest of Asia-Pacific Market Size And Forecast, By Indication
7.4.3. Asia-Pacific Market Size And Forecast, By Service Type
7.4.4. Asia-Pacific Market Size And Forecast, By Animal Type
7.4.5. Asia-Pacific Market Size And Forecast, By Indication
7.5. LAMEA
7.5.1. Key Market Trends And Opportunities
7.5.2. Market Analysis By Country
7.5.2.1. Brazil
7.5.2.1.1. Brazil Market Size And Forecast, By Service Type
7.5.2.1.2. Brazil Market Size And Forecast, By Animal Type
7.5.2.1.3. Brazil Market Size And Forecast, By Indication
7.5.2.2. South Africa
7.5.2.2.1. South Africa Market Size And Forecast, By Service Type
7.5.2.2.2. South Africa Market Size And Forecast, By Animal Type
7.5.2.2.3. South Africa Market Size And Forecast, By Indication
7.5.2.3. Saudi Arabia
7.5.2.3.1. Saudi Arabia Market Size And Forecast, By Service Type
7.5.2.3.2. Saudi Arabia Market Size And Forecast, By Animal Type
7.5.2.3.3. Saudi Arabia Market Size And Forecast, By Indication
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA Market Size And Forecast, By Service Type
7.5.2.4.2. Rest of LAMEA Market Size And Forecast, By Animal Type
7.5.2.4.3. Rest of LAMEA Market Size And Forecast, By Indication
7.5.3. LAMEA Market Size And Forecast, By Service Type
7.5.4. LAMEA Market Size And Forecast, By Animal Type
7.5.5. LAMEA Market Size And Forecast, By Indication

Chapter 8: Competitive Landscape
8.1. Introduction
8.1.1. Market Player Positioning, 2018
8.2. Top Winning Strategies And Key Developments
8.3. Competitive Dashboard
8.4. Competitive Heatmap

Chapter 9: Company Profiles
9.1. Charles River Laboratories, Inc.
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Product Portfolio
9.1.5. Business Performance
9.1.6. Key Strategic Moves And Developments
9.2. Clinvet
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments
9.2.4. Product Portfolio
9.2.5. Key Strategic Moves And Developments
9.3. Klifovet Ag
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments
9.3.4. Product Portfolio
9.4. Löhlein & Wolf Vet Research
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.4.5. Key Strategic Moves And Developments
9.5. Oncovet Clinical Research
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio
9.6. Ondax Scientific
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Product Portfolio
9.6.5. Key Strategic Moves And Developments
9.7. Triveritas
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments
9.7.4. Product Portfolio
9.8. Veterinary Research Management (Vrm) Ltd
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Product Portfolio
9.9. Vetpharm, Inc.
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Operating Business Segments
9.9.4. Product Portfolio
9.10. Vetspin Srl
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Operating Business Segments
9.10.4. Product Portfolio
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Clinvet
  • KLIFOVET AG
  • Oncovet Clinical Research
  • ONDAX Scientific
  • Triveritas
  • VetPharm Inc.
  • MORE
According to the report titled, 'Veterinary CRO Market by Service Type, Animal Type, and Indication: Global Opportunity Analysis and Industry Forecast, 2018-2026', the global veterinary CRO market size was valued at $714.00 million in 2018, and is expected to reach $1,331.40 billion by 2026, registering a CAGR of 8.1% from 2019 to 2026.

Veterinary CROs are organizations that provide support to the veterinary medicine manufacturers in the form of services. For instance, clinical trials involve the handling of large number of animals, which require specially designed facilities; therefore, veterinary CROs manage clinical trials for companies, which are engaged in introduction of new veterinary medications. Similarly, the other services offered by veterinary CROs include regulatory support and market authorization process related to veterinary drugs. Furthermore, these organizations perform toxicology studies related to veterinary drugs to analyze the safety and efficacy related to veterinary drugs. In addition, veterinary CROs conduct clinical trials for various indications in animals such as oncology, neurology, infectious diseases, and others.

Rise in ownership of companion animals and a surge in animal health expenditure are the major factors that boost the growth of global veterinary CRO market. In addition, increase in prevalence of various diseases among companion animals significantly drives the growth of the market. However, lack of standardization in veterinary CROs acts as a major restraint of the market. On the contrary, a surge in awareness related to animal healthcare across the globe is expected to offer remunerative opportunities for market expansion during the forecast period.

The Veterinary CRO market is segmented into service type, animal type, indication, and region. As per service type, the market is segregated into clinical trials, toxicology, market authorization & regulatory support, and others.

Depending on animal type, it is fragmented into dogs, cats, and others. Depending on indication, it is categorized into oncology, infectious disease, neurology, and others. Region wise, it is analyzed across North America (U.S, Canada, and Mexico) and Europe (Germany, France, Italy, Spain, UK and rest of Europe), Asia-Pacific (Japan, China, Australia, rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).

By service type, the clinical trials is the largest segment in the veterinary CRO market in terms of revenue contribution, and is expected to exhibit the fastest growth rate during the forecast period. This is attributed to an increase in outsourcing of clinical trials, owing to its extensive nature due to which the entire process becomes lengthy and expensive. Thus, veterinary medicine manufacturing companies outsource clinical trials to veterinary CROs for managing the lengthy procedure, which also involve the handling of large number of animals in specialized facilities. Therefore, this factor considerably boosts the demand for clinical trial services offered by veterinary CROs.

By animal type, the dog segment acquired the major share of the global veterinary CRO market, and is expected to exhibit the fastest growth rate during the forecast period, owing to a surge in ownership of dogs as companion animals worldwide. Furthermore, a surge in awareness related to dog health among their owners is another major factor that augments the growth of this segment.

Region wise, North America acquired a major share, owing to easy availability of CRO products in the region, a surge in pet ownership, and increase in the animal healthcare expenditure. However, Europe is expected to grow at the highest rate during the forecast period, due to a surge in awareness related to animal health among owners. In addition, presence of majority of key players in Europe boots the growth of the market in this region.

Key Findings of the Study::

By service type, the clinical trials segment accounted for a share of one-thirds share in the veterinary CRO market in 2018.
Region wise, Asia-Pacific is anticipated to grow at the highest CAGR of 9.4% throughout the forecast period.
Rest of Europe accounted for one-thirds share of the veterinary CRO market, in 2018.
By animal type, others segment accounted for a one-fourths share of in the veterinary CRO market in 2018.
Note: Product cover images may vary from those shown
4 of 5
  • Charles River Laboratories Inc.
  • Clinvet
  • KLIFOVET AG
  • Löhlein & Wolf Vet Research
  • Oncovet Clinical Research
  • ONDAX Scientific
  • Triveritas
  • Veterinary Research Management (VRM) Ltd
  • VetPharm Inc.
  • VETSPIN SRL.
Note: Product cover images may vary from those shown
5 of 5

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll